Cargando…
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of hyperthyroidism and hypothyroidism
This manuscript provides guidance on the management of thyroid dysfunction during the COVID-19 pandemic. Autoimmune thyroid diseases are not linked to increased risks of COVID-19. Uncontrolled thyrotoxicosis may result in more severe complications from SARS-CoV-2 infection, including thyroid storm....
Autores principales: | Boelaert, Kristien, Visser, W Edward, Taylor, Peter Nicholas, Moran, Carla, Léger, Juliane, Persani, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938012/ https://www.ncbi.nlm.nih.gov/pubmed/32438340 http://dx.doi.org/10.1530/EJE-20-0445 |
Ejemplares similares
-
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of thyroid nodules and cancer
por: Vrachimis, Alexis, et al.
Publicado: (2020) -
Endocrinology in the time of COVID-19: Management of pituitary tumours
por: Fleseriu, Maria, et al.
Publicado: (2020) -
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of Cushing's syndrome
por: Newell-Price, John, et al.
Publicado: (2020) -
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency
por: Arlt, Wiebke, et al.
Publicado: (2020) -
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of diabetes insipidus and hyponatraemia
por: Christ-Crain, Mirjam, et al.
Publicado: (2020)